Full Text
PND42 COST-EFFECTIVENESS ANALYSIS OF ERENUMAB VERSUS TOPIRAMATE FOR PATIENTS WITH CHRONIC MIGRAINES TO IDENTIFY THE COST-EFFECTIVE PRICE THRESHOLD IN GREECE

Abstract

Authors

T. Giannouchos R.L. Ohsfeldt

Back to Volume 22, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×